Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Seizures × Solutions × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Melanoma 3 Uveal Melanoma 1 Tuberous Sclerosis 1 Seizures 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lennox Gastaut Syndrome 1 Hematologic Neoplasms 1 Glioblastoma 1 Epilepsies, Myoclonic 1

Interventions

Levetiracetam 2 Cannabidiol 2 Solutions 1 Lenalidomide 1 Everolimus 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡